Literature DB >> 17705264

Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice.

Ryotaro Sakamori1, Tetsuo Takehara, Chihiro Ohnishi, Tomohide Tatsumi, Kazuyoshi Ohkawa, Kiyoshi Takeda, Shizuo Akira, Norio Hayashi.   

Abstract

UNLABELLED: Sepsis is an infection-induced syndrome with systemic inflammatory response leading to multiorgan failure and occasionally death. During this process, signal transducer and activator of transcription 3 (STAT3) is activated in the liver, but the significance of this molecule has not been established. We generated hepatocyte-specific STAT3-deficient mice (L-STAT3 KO) and examined the susceptibility of these mice to cecal ligation and puncture-induced peritonitis, a well-established septic model. L-STAT3 KO mice showed significantly higher mortality and produced lesser amounts of various acute phase proteins than control littermates. Although blood bacterial infection did not differ between L-STAT3 KO mice and control mice, the former showed deterioration of the systemic inflammatory response as evidenced by a significant increase in various cytokines such as tumor necrosis factor alpha, IFN-gamma, IL-6, IL-10, monocyte chemoattractant protein 1, and macrophage inflammatory protein 1beta. A similar hyperinflammatory response was observed in another septic model caused by lipopolysaccharide (LPS) injection. In vitro analysis revealed that soluble substances derived from hepatocytes and dependent on STAT3 were critical for suppression of cytokine production from LPS-stimulated macrophage and splenocytes.
CONCLUSION: STAT3 activation in hepatocytes can attenuate a systemic hyperinflammatory response and lethality in sepsis, in part by suppressing immune cell overactivation, implying a critical role of hepatocyte STAT3 signaling in maintaining host homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705264     DOI: 10.1002/hep.21837

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  New Approaches for Studying Alcoholic Liver Disease.

Authors:  Jun Xu; Xiao Liu; Bin Gao; Michael Karin; Hidekazu Tsukamoto; David Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2014-09-14

2.  Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.

Authors:  Benting Ma; Junjie Zhu; Juan Tan; Yulei Mao; Lingyun Tang; Chunling Shen; Hongxing Zhang; Ying Kuang; Jian Fei; Xiao Yang; Zhugang Wang
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

3.  Hepatic STAT3 inhibition amplifies the inflammatory response in obese mice during sepsis.

Authors:  Lauren Williamson; Itay Ayalon; Hui Shen; Jennifer Kaplan
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-21       Impact factor: 4.310

4.  Roles of STAT3 in protein secretion pathways during the acute-phase response.

Authors:  Ayele-Nati N Ahyi; Lee J Quinton; Matthew R Jones; Joseph D Ferrari; Zachary A Pepper-Cunningham; Juan R Mella; Daniel G Remick; Joseph P Mizgerd
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

Review 5.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

6.  High fat diet-induced obesity increases myocardial injury and alters cardiac STAT3 signaling in mice after polymicrobial sepsis.

Authors:  Theodore DeMartini; Marchele Nowell; Jeanne James; Lauren Williamson; Patrick Lahni; Hui Shen; Jennifer M Kaplan
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-15       Impact factor: 5.187

7.  Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice.

Authors:  Takahiro Kodama; Tetsuo Takehara; Hayato Hikita; Satoshi Shimizu; Minoru Shigekawa; Hinako Tsunematsu; Wei Li; Takuya Miyagi; Atsushi Hosui; Tomohide Tatsumi; Hisashi Ishida; Tatsuya Kanto; Naoki Hiramatsu; Satoshi Kubota; Masaharu Takigawa; Yoshito Tomimaru; Akira Tomokuni; Hiroaki Nagano; Yuichiro Doki; Masaki Mori; Norio Hayashi
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

8.  Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

Authors:  Tharini Sivasubramaniyam; Stephanie A Schroer; Angela Li; Cynthia T Luk; Sally Yu Shi; Rickvinder Besla; David W Dodington; Adam H Metherel; Alex P Kitson; Jara J Brunt; Joshua Lopes; Kay-Uwe Wagner; Richard P Bazinet; Michelle P Bendeck; Clinton S Robbins; Minna Woo
Journal:  JCI Insight       Date:  2017-07-20

Review 9.  Sepsis: links between pathogen sensing and organ damage.

Authors:  Elliott Crouser; Matthew Exline; Daren Knoell; Mark D Wewers
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo.

Authors:  Ryotaro Sakamori; Tetsuo Takehara; Tomohide Tatsumi; Minoru Shigekawa; Hayato Hikita; Naoki Hiramatsu; Tatsuya Kanto; Norio Hayashi
Journal:  J Gastroenterol       Date:  2009-12-01       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.